revenue recognition

Restoring Integrity: MiMedx CFO Pete Carlson
Q&A

Restoring Integrity: MiMedx CFO Pete Carlson

CFO Carlson helps biologics company MiMedx recover from an episode of revenue recognition fraud.
By Vincent Ryan | June 30, 2022
Read More
Former WageWorks CFO, CEO Settle Accounting Case
Risk & Compliance

Former WageWorks CFO, CEO Settle Accounting Case

Ex-CEO Joseph Jackson and ex-CFO Colm Callan allegedly made false statements that resulted in the improper recognition of $3.6 million in revenue.
By Matthew Heller | February 3, 2021
Read More
Three Former Manitex Execs Charged With Fraud
Risk & Compliance

Three Former Manitex Execs Charged With Fraud

Former CFO Michael Schneider and two colleagues allegedly engaged in schemes that resulted in the crane maker’s revenue and profit being overstated.
By Matthew Heller | October 1, 2020
Read More
Power Solutions Fined for Accounting Fraud
Risk & Compliance

Power Solutions Fined for Accounting Fraud

The engine maker's former CEO and two other executives allegedly orchestrated transactions to inflate the company's revenue by almost $25 million.
By Matthew Heller | September 25, 2020
Read More
Technical Accounting: The CFO’s Secret Weapon
Revenue Recognition

Technical Accounting: The CFO’s Secret Weapon

A great partnership with accounting will actually help drive and influence financial results (legally, of course).
By Shauna Watson | January 21, 2020
Read More
SEC Charges Former MiMedx Execs With Fraud
Risk & Compliance

SEC Charges Former MiMedx Execs With Fraud

The C-suite executives allegedly improperly recognized revenue from distributors with which MiMedx had secret side arrangements.
By Matthew Heller | November 27, 2019
Read More
Ex-Outcome Health Execs Charged With Fraud
Risk & Compliance

Ex-Outcome Health Execs Charged With Fraud

The SEC says the CFO and two other executives misrepresented Outcome's financial performance to raise nearly $500 million from investors.
By Matthew Heller | November 26, 2019
Read More
Unclear IR Communications Sent Share Price Tumbling
Risk & Compliance

Unclear IR Communications Sent Share Price Tumbling

New CFO at Talend works to overcome investor concerns about the software firm's altered business model and revenue recognition issues.
By David McCann | May 28, 2019
Read More
AICPA Urges Delay of Lease Accounting Rules
Growth Companies

AICPA Urges Delay of Lease Accounting Rules

FASB should postpone the effective date of the “significant and complex” ASC 842 for a year for private companies, AICPA says.
By Matthew Heller | May 15, 2019
Read More
The New Accounting for Collaborative Arrangements
Revenue Recognition

The New Accounting for Collaborative Arrangements

Here's what you need to know about FASB's new guidance on "collaborative arrangements" between entities.
By David McCann | March 19, 2019
Read More
ASC 606: Trips, Traps, and Troubleshooting
Growth Companies

ASC 606: Trips, Traps, and Troubleshooting

Clever private company CFOs can learn from the mistakes, pitfalls, and land mines that tripped up their public company peers last year.
By Alex Bogopolsky | January 24, 2019
Read More
SEC: Telecom Firm Artificially Boosted Revenue
Risk & Compliance

SEC: Telecom Firm Artificially Boosted Revenue

How many schemes did telecom expense management company Tangoe have for recognizing revenue improperly and hiding its pre-tax losses?
By Vincent Ryan | September 5, 2018
Read More
16 Years Later, SOX Compliance Continues to Evolve
Robotic Process Automation

16 Years Later, SOX Compliance Continues to Evolve

Sarbanes-Oxley compliance costs shot up this year, underscoring the need for companies to automate more of their compliance activities.
By David McCann | August 13, 2018
Read More
New Accounting Rules Test Companies’ Mettle
Risk & Compliance

New Accounting Rules Test Companies’ Mettle

Forty-two percent of public companies are either still assessing the impact of the new lease accounting rules or have not even gotten that far, finds PwC.
By David McCann | June 8, 2018
Read More
MiMedx Announces Restatement, Replaces CFO
People

MiMedx Announces Restatement, Replaces CFO

The biotech firm's stock falls 23% but its CEO says, "It is important that investors understand that our business performance remains strong."
By Matthew Heller | June 7, 2018
Read More
Next